How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention? (Q37309753)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 October 2008
edit
Language Label Description Also known as
English
How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention?
scientific article published on 26 October 2008

    Statements

    How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention? (English)
    Ann Lovold
    Cynthia Stanton
    Deborah Armbruster
    26 October 2008
    276-282

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit